# Point Mutation in DNA: Types, Mechanisms, and Disease

## Introduction to Point Mutations in DNA

### What Is a Point Mutation?

A point mutation is a change in a single nucleotide base pair within a DNA molecule. The human genome contains approximately 3.2 billion base pairs, and a point mutation represents the smallest possible unit of genetic change—the substitution, insertion, or deletion of just one nucleotide. Despite this minimal scale, point mutations can have profound consequences for gene function, protein structure, and organismal health.

In molecular terms, a point mutation occurs when a single base, such as adenine (A), thymine (T), guanine (G), or cytosine (C), is replaced by a different base, or when a single base is added or removed from the sequence. The position of the mutation determines its effect: a change in a non-coding region may have little or no impact, while a change in a protein-coding exon can alter the amino acid sequence of the resulting protein. For a more detailed treatment of the fundamental concept, see the [Point Mutation Definition](/knowledge/molecular-biology/point-mutation-definition).

### Why Point Mutations Matter

Point mutations are the raw material of evolution, providing the genetic variation upon which natural selection acts. However, they are also the underlying cause of thousands of human diseases, including sickle cell anemia, cystic fibrosis, and numerous cancers. Understanding point mutations is essential for several reasons:

1. **Disease diagnosis**: Many genetic disorders are diagnosed by identifying specific point mutations in patient DNA.
2. **Cancer genomics**: Tumor cells accumulate point mutations in oncogenes and [tumor suppressor genes](/knowledge/molecular-biology/tumor-suppressor-gene), driving malignant transformation.
3. **Pharmacogenomics**: Point mutations can affect drug metabolism, influencing individual responses to medications.
4. **Evolutionary biology**: Comparing point mutations across species reveals evolutionary relationships and molecular clocks.

The study of point mutations bridges basic molecular biology with clinical medicine, making it a cornerstone of modern genetics education.

## Types of Point Mutations

Point mutations are classified into two broad categories: substitutions and indels (insertions or deletions). Each category has distinct subtypes with different molecular consequences.

### Substitutions: Transitions and Transversions

A substitution replaces one nucleotide with another. Substitutions are further divided into two types based on the chemical nature of the bases involved:

**Transitions** are substitutions where a purine (A or G) is replaced by another purine, or a pyrimidine (T or C) is replaced by another pyrimidine. Examples include A→G, G→A, T→C, and C→T. Transitions are more common than transversions, partly because of the chemistry of base mispairing during DNA replication.

**Transversions** are substitutions where a purine is replaced by a pyrimidine, or vice versa. Examples include A→T, A→C, G→T, and G→C. Transversions are less frequent than transitions, occurring at roughly one-third to one-half the rate, because they require more substantial changes in base structure and hydrogen bonding patterns.

The distinction between transitions and transversions matters for understanding mutation spectra—the characteristic patterns of mutations associated with specific mutagens or repair deficiencies. For example, ultraviolet radiation predominantly causes C→T transitions, while tobacco smoke mutagens often cause G→T transversions.

### Insertions and Deletions (Indels)

Insertions add one or more nucleotides to a DNA sequence, while deletions remove nucleotides. When a single nucleotide is inserted or deleted in a protein-coding region, the mutation is called a **frameshift mutation** because it shifts the reading frame of the genetic code. The ribosome reads mRNA in triplets (codons), and adding or removing one nucleotide disrupts this triplet grouping, altering every subsequent amino acid in the protein.

For example, consider the sequence ATG GGA CCT TAA, which encodes Met-Gly-Pro-Stop. If an adenine is inserted after the first codon, the sequence becomes ATG AGG ACC TTA A—now encoding Met-Arg-Thr-Leu, with a completely different protein sequence and a shifted stop codon. The earlier the frameshift occurs in the coding sequence, the more devastating the effect, as a larger portion of the protein is altered. For a comprehensive explanation of this mechanism, refer to the [Frameshift Mutation](/knowledge/molecular-biology/frameshift-mutation) resource.

Indels of three nucleotides or multiples of three do not cause frameshifts because they add or remove whole codons, preserving the reading frame. Such in-frame indels may add or delete amino acids but do not disrupt the rest of the protein.

## Molecular Mechanisms of Point Mutation Formation

Point mutations arise through two principal routes: spontaneous errors during DNA replication and repair, and induced damage from environmental mutagens.

### Spontaneous Mutations

Spontaneous mutations occur without external influence, arising from the inherent chemical instability of DNA and the finite fidelity of DNA polymerases. Several mechanisms contribute:

**Tautomeric shifts**: Each DNA base can exist in alternative chemical forms called tautomers, which differ in the position of a hydrogen atom and the location of double bonds. The keto forms of guanine and thymine can shift to enol forms, while the amino forms of adenine and cytosine can shift to imino forms. These rare tautomers (occurring in roughly 1 in 10⁴ to 10⁵ bases) can form non-standard base pairs during replication. For instance, the enol form of thymine can pair with guanine instead of adenine, leading to a T→C transition after the next round of replication.

**Depurination**: The glycosidic bond linking a purine base (A or G) to the deoxyribose sugar can hydrolyze spontaneously, creating an apurinic (AP) site. This occurs at a rate of approximately 10,000 purine losses per human cell per day. During replication, DNA polymerases often insert an adenine opposite an AP site (the "A-rule"), potentially causing a mutation.

**Deamination**: Cytosine can undergo spontaneous deamination to form uracil, which pairs with adenine instead of guanine. If unrepaired, this leads to a C→T transition. Similarly, 5-methylcytosine (a modified base involved in gene regulation) deaminates to thymine, also causing C→T transitions. This explains why CpG dinucleotides are mutation hotspots in the human genome.

**Replication errors**: DNA polymerases have error rates of approximately 10⁻⁵ to 10⁻⁶ per base pair per replication cycle, despite their proofreading activity. Most errors are mismatches that are corrected by the mismatch repair system, reducing the final mutation rate to about 10⁻⁹ to 10⁻¹⁰ per base pair per generation.

### Induced Mutations by Mutagens

Mutagens are environmental agents that increase mutation rates by damaging DNA or subverting the replication machinery.

**Chemical mutagens** include:

- **Base analogs**: Compounds like 5-bromouracil (5-BU) resemble thymine and can be incorporated into DNA during replication. 5-BU can tautomerize and pair with guanine, causing T→C transitions.
- **Alkylating agents**: Compounds such as ethyl methanesulfonate (EMS) and N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) add alkyl groups to bases, particularly guanine at the O⁶ position. O⁶-methylguanine pairs with thymine rather than cytosine, causing G→A transitions.
- **Deaminating agents**: Nitrous acid (HNO₂) converts cytosine to uracil, adenine to hypoxanthine, and guanine to xanthine, each of which mispairs during replication.
- **Intercalating agents**: Planar molecules like ethidium bromide and acridine orange insert between adjacent base pairs, causing single-nucleotide insertions or deletions during replication.

**Radiation**:

- **Ultraviolet (UV) light** causes adjacent pyrimidines (especially thymines) to form covalent bonds, creating cyclobutane pyrimidine dimers and 6-4 photoproducts. These lesions distort the DNA helix and cause replication errors, typically C→T transitions.
- **Ionizing radiation** (X-rays, gamma rays) generates reactive oxygen species that oxidize bases, particularly guanine to 8-oxoguanine, which mispairs with adenine, causing G→T transversions. Ionizing radiation also causes single- and double-strand breaks.

## Effects of Point Mutations on Protein Structure and Function

The consequence of a point mutation in a coding region depends on how it alters the genetic code. The genetic code is degenerate—most amino acids are encoded by multiple codons—which provides a buffer against some mutations.

### Silent Mutations

A silent mutation changes a codon to a different codon that encodes the same amino acid. For example, changing GAA to GAG both encode glutamic acid. Because the protein sequence is unchanged, silent mutations are often considered "neutral." However, this is not always true:

- Silent mutations can affect mRNA splicing by altering exonic splicing enhancers or silencers.
- They can change mRNA secondary structure, affecting stability and translation efficiency.
- They can alter codon usage, influencing translation speed and protein folding.

For these reasons, silent mutations are increasingly recognized as potentially pathogenic. The distinction between a silent mutation and a neutral polymorphism is an important nuance in clinical genetics.

### Missense Mutations

A missense mutation changes a codon to encode a different amino acid. The effect depends on the chemical difference between the original and substituted amino acid:

- **Conservative missense mutations** replace an amino acid with a chemically similar one (e.g., aspartic acid to glutamic acid, both acidic). These often have mild effects.
- **Non-conservative missense mutations** replace an amino acid with a chemically different one (e.g., hydrophobic valine to hydrophilic glutamic acid). These can severely disrupt protein structure and function.

The classic example is the sickle cell mutation in the β-globin gene (HBB), where a single A→T transversion changes codon 6 from GAG (glutamic acid) to GTG (valine). This single amino acid substitution creates a hydrophobic patch on the hemoglobin surface, causing polymerization of deoxygenated hemoglobin and sickling of red blood cells. For a deeper comparison of these concepts, see [Point Mutation vs Missense](/knowledge/molecular-biology/point-mutation-vs-missense).

### Nonsense Mutations

A nonsense mutation changes a codon to a stop codon (UAA, UAG, or UGA), prematurely terminating translation. The resulting protein is truncated, missing its C-terminal portion. Nonsense mutations are generally severe because:

- The truncated protein often lacks critical functional domains.
- [Nonsense-mediated mRNA decay](/knowledge/molecular-biology/nonsense-mediated-mrna-decay) may degrade the transcript, eliminating protein production entirely.
- Dominant-negative effects can occur if the truncated protein interferes with normal protein function.

Nonsense mutations account for approximately 10-15% of all disease-causing mutations. For example, many cases of Duchenne muscular dystrophy result from nonsense mutations in the dystrophin gene (DMD), producing a severely truncated, nonfunctional protein.

### Frameshift Mutations

Frameshift mutations, caused by insertions or deletions of nucleotides not in multiples of three, alter the reading frame from the mutation point onward. The consequences are usually catastrophic:

- Every amino acid downstream of the mutation is changed.
- A premature stop codon is often encountered, truncating the protein.
- The protein, if produced, is typically nonfunctional and may be degraded.

Frameshift mutations are particularly common in regions of repetitive DNA, where replication slippage can occur. For example, the CFTR gene contains a hotspot of frameshift mutations in exon 10, where a string of thymines is prone to polymerase slippage.

## Point Mutations in Human Disease

Point mutations underlie a vast array of human diseases, from rare Mendelian disorders to common cancers. Understanding the molecular basis of these diseases provides insight into both pathogenesis and therapeutic strategies.

### Sickle Cell Anemia: A Classic Missense Mutation

Sickle cell anemia is caused by a single A→T transversion in the HBB gene, changing codon 6 from GAG (glutamic acid) to GTG (valine). This substitution replaces a charged, hydrophilic amino acid with a hydrophobic one at position 6 of the β-globin chain.

The molecular mechanism of disease involves:

1. Under low oxygen conditions, deoxygenated hemoglobin S molecules polymerize into long fibers.
2. These fibers distort red blood cells into the characteristic sickle shape.
3. Sickled cells are rigid and obstruct blood vessels, causing vaso-occlusive crises.
4. Sickled cells are also destroyed more rapidly, leading to chronic hemolytic anemia.

The heterozygous state (sickle cell trait) confers resistance to malaria, explaining the high frequency of the mutation in malaria-endemic regions. This is a classic example of balancing selection maintaining a deleterious mutation.

### Cystic Fibrosis: Deletion and Frameshift

Cystic fibrosis is caused by mutations in the CFTR gene, which encodes a chloride channel. The most common mutation, ΔF508, is a deletion of three nucleotides that removes a phenylalanine at position 508. While this is an in-frame deletion (not a frameshift), it causes the protein to misfold and be degraded in the endoplasmic reticulum before reaching the cell membrane.

Other CFTR mutations include:

- **G542X**: A nonsense mutation (glycine to stop) that truncates the protein.
- **G551D**: A missense mutation that produces a channel that reaches the membrane but fails to open properly.
- **W1282X**: A nonsense mutation causing premature termination.

The severity of cystic fibrosis correlates with the mutation class. Class I mutations (nonsense, frameshift) produce no functional protein and cause severe disease, while class IV mutations (defective conductance) may allow some residual function and milder symptoms.

### Oncogenes and Tumor Suppressors

Cancer is fundamentally a genetic disease, and point mutations play a central role in its initiation and progression. Two major classes of genes are involved:

**Oncogenes** are activated by gain-of-function mutations. A single mutated allele can drive uncontrolled cell proliferation. Examples include:

- **RAS genes** (HRAS, KRAS, NRAS): Point mutations at codons 12, 13, or 61 lock the RAS protein in its active GTP-bound state, causing continuous signaling through the MAPK pathway. KRAS mutations occur in approximately 25% of all human cancers.
- **BRAF**: The V600E mutation (valine to glutamic acid at position 600) constitutively activates the kinase, driving melanoma and other cancers.
- **EGFR**: Mutations in the tyrosine kinase domain cause constitutive activation in lung cancer.

**Tumor suppressor genes** are inactivated by loss-of-function mutations. Both alleles must typically be mutated for loss of function (the "two-hit hypothesis"). Examples include:

- **TP53**: The most frequently mutated gene in human cancer, with over 50% of tumors harboring TP53 mutations. Most are missense mutations in the DNA-binding domain, producing a nonfunctional protein that cannot activate cell cycle arrest or apoptosis.
- **RB1**: Mutations in the retinoblastoma gene cause hereditary retinoblastoma and contribute to other cancers.
- **APC**: Mutations in the adenomatous polyposis coli gene initiate colorectal cancer.

The spectrum of point mutations in cancer genomes is not random; it reflects the mutagenic processes that drove tumorigenesis. For example, UV-associated melanomas show a predominance of C→T transitions at dipyrimidine sites, while smoking-associated lung cancers show G→T transversions.

## Methods for Detecting and Analyzing Point Mutations

Identifying point mutations is essential for diagnosis, prognosis, and treatment selection. Multiple techniques are available, each with distinct advantages and limitations.

### Sanger Sequencing and Next-Generation Sequencing

**Sanger sequencing** (dideoxy chain termination) was the first widely used method for detecting point mutations. The process involves:

1. PCR amplification of the target region.
2. A sequencing reaction with fluorescently labeled dideoxynucleotides that terminate chain elongation.
3. Capillary electrophoresis to separate fragments by size.
4. Computational analysis to determine the sequence.

Sanger sequencing has a read length of 600-1000 base pairs and can detect heterozygous mutations as mixed peaks in the electropherogram. It remains the gold standard for validating mutations identified by other methods.

**Next-generation sequencing (NGS)** enables massively parallel sequencing of millions of DNA fragments simultaneously. Whole-genome sequencing (WGS) and whole-exome sequencing (WES) can identify point mutations across the entire genome or all protein-coding regions. NGS platforms include Illumina (sequencing by synthesis), Ion Torrent (semiconductor sequencing), and Oxford Nanopore (real-time sequencing). The choice of platform depends on throughput needs, read length requirements, and cost considerations.

### PCR and RFLP Analysis

**Restriction fragment length polymorphism (RFLP) analysis** exploits the fact that some point mutations create or destroy restriction enzyme recognition sites. The procedure involves:

1. PCR amplification of the region containing the suspected mutation.
2. Digestion with a restriction enzyme whose site is affected by the mutation.
3. Gel electrophoresis to visualize fragment patterns.

For example, the sickle cell mutation destroys an MstII restriction site in the HBB gene. After digestion, normal alleles produce fragments of 1.15 kb and 0.20 kb, while mutant alleles produce a single 1.35 kb fragment. This simple test can distinguish normal, heterozygous, and homozygous genotypes.

### Allele-Specific PCR and Microarrays

**Allele-specific PCR** (also called amplification-refractory mutation system, ARMS) uses primers whose 3' ends are complementary to either the wild-type or mutant allele. Because DNA polymerase requires a perfect match at the 3' end, amplification occurs only when the primer matches the template. By designing separate primers for each allele and running parallel reactions, the genotype can be determined.

**TaqMan probes** use allele-specific oligonucleotides labeled with different fluorophores. During PCR, the probe hybridizes to its complementary sequence, and the 5' nuclease activity of Taq polymerase cleaves the probe, releasing the fluorophore. The ratio of fluorescence from wild-type and mutant probes indicates the genotype.

**DNA microarrays** (gene chips) contain thousands of allele-specific oligonucleotide probes immobilized on a solid surface. Labeled patient DNA is hybridized to the array, and the pattern of hybridization reveals the presence of specific mutations. This approach is used for screening panels of known mutations, such as in the CFTR gene.

## Repair Mechanisms and Mutation Frequency

Cells have evolved multiple DNA repair pathways to correct point mutations and maintain genomic integrity. When these pathways fail, mutation rates increase dramatically, predisposing to cancer and other diseases.

### [Base Excision Repair](/knowledge/molecular-biology/base-excision-repair)

[Base excision repair](/knowledge/molecular-biology/base-excision-repair) (BER) corrects small, non-helix-distorting base lesions, such as those caused by deamination, oxidation, or alkylation. The pathway involves:

1. **DNA glycosylase** recognizes and removes the damaged base, creating an apurinic/apyrimidinic (AP) site. Each glycosylase is specific for a particular lesion type (e.g., uracil DNA glycosylase removes uracil, OGG1 removes 8-oxoguanine).
2. **AP endonuclease** (APE1) nicks the DNA backbone at the AP site.
3. **DNA polymerase β** fills the gap with the correct nucleotide.
4. **DNA ligase III** seals the nick.

BER operates in both the nucleus and mitochondria and is essential for repairing the ~10,000 depurination events and ~200 deamination events that occur per cell per day.

### [Nucleotide Excision Repair](/knowledge/molecular-biology/nucleotide-excision-repair)

[Nucleotide excision repair](/knowledge/molecular-biology/nucleotide-excision-repair) (NER) removes bulky, helix-distorting lesions, such as UV-induced pyrimidine dimers and chemical adducts. The pathway involves:

1. **Damage recognition**: The XPC-RAD23B complex (in global genomic NER) or stalled RNA polymerase (in transcription-coupled NER) recognizes the lesion.
2. **Unwinding**: TFIIH helicase subunits XPB and XPD unwind the DNA around the lesion.
3. **Dual incision**: XPG cuts 3' to the lesion, and ERCC1-XPF cuts 5', removing a 24-32 nucleotide oligonucleotide.
4. **Resynthesis**: DNA polymerase δ or ε fills the gap.
5. **Ligation**: DNA ligase I seals the nick.

Defects in NER cause xeroderma pigmentosum, a condition characterized by extreme UV sensitivity and a >1000-fold increased risk of skin cancer.

### Mismatch Repair

Mismatch repair (MMR) corrects replication errors—base-base mismatches and small insertion-deletion loops that escape polymerase proofreading. The pathway in humans involves:

1. **Recognition**: MutS homologs (MSH2-MSH6 for base mismatches, MSH2-MSH3 for small loops) bind the mismatch.
2. **Recruitment**: MutL homologs (MLH1-PMS2) are recruited to the complex.
3. **Excision**: The newly synthesized strand is excised from the mismatch back to a nearby nick.
4. **Resynthesis**: DNA polymerase δ fills the gap.
5. **Ligation**: DNA ligase I seals the nick.

MMR must distinguish the newly synthesized strand from the template strand. In E. coli, this is achieved by methylation of adenine in GATC sequences on the template strand. In humans, the mechanism is less clear but may involve the presence of strand discontinuities in the newly synthesized DNA.

Defects in MMR cause Lynch syndrome (hereditary non-polyposis colorectal cancer), characterized by microsatellite instability and a greatly increased risk of colorectal, endometrial, and other cancers.

## Common Pitfalls and Misconceptions

Students frequently encounter several conceptual difficulties when learning about point mutations. Understanding these pitfalls is essential for exam success and accurate clinical reasoning.

### Point Mutation vs. Chromosomal Mutation

A point mutation affects a single nucleotide, while a chromosomal mutation involves changes in [chromosome structure](/knowledge/molecular-biology/chromosome-structure) or number. Chromosomal mutations include deletions, duplications, inversions, and translocations of large DNA segments, as well as aneuploidy (abnormal chromosome number). These are fundamentally different in scale and mechanism. A point mutation cannot be detected by karyotyping, while chromosomal mutations often can. Conversely, point mutations require sequence-level analysis for detection.

### Silent Mutations Are Not Always Neutral

The term "silent" refers to the amino acid sequence, not the phenotype. Silent mutations can have functional consequences through several mechanisms:

- **Splicing alterations**: Silent mutations can disrupt exonic splicing enhancers, causing exon skipping.
- **mRNA stability**: Changes in codon usage can affect mRNA secondary structure and stability.
- **Translation kinetics**: Rare codons slow translation, which can affect co-translational protein folding.

Approximately 1-3% of silent mutations in disease genes are pathogenic, a fact that challenges the assumption of neutrality.

### Reading Frame Confusion

The reading frame is the grouping of nucleotides into codons, starting from the initiation codon (AUG). A frameshift mutation changes this grouping, but students often confuse the effects of insertions/deletions of different sizes:

- **1 or 2 nucleotides**: Frameshift, altering all downstream codons.
- **3 nucleotides**: In-frame, adding or deleting one amino acid.
- **4 or 5 nucleotides**: Frameshift, altering all downstream codons.
- **6 nucleotides**: In-frame, adding or deleting two amino acids.

The rule is simple: only indels that are multiples of three preserve the reading frame. This distinction is critical for predicting mutation severity.

## Frequently Asked Questions

### What is a point mutation in DNA?

A point mutation is a change in a single nucleotide base pair in DNA. It can be a substitution (one base replaced by another), an insertion (one base added), or a deletion (one base removed). Point mutations are the smallest possible genetic changes and can occur in coding or non-coding regions of the genome.

### What are the types of point mutations?

Point mutations are classified as substitutions (transitions and transversions) and indels (insertions and deletions). Substitutions replace one base with another; transitions swap purine for purine or pyrimidine for pyrimidine, while transversions swap purine for pyrimidine or vice versa. Indels add or remove nucleotides, potentially causing frameshifts if the number is not a multiple of three.

### How do point mutations affect proteins?

The effect depends on the mutation type. Silent mutations do not change the amino acid sequence. Missense mutations change one amino acid, which may or may not affect protein function. Nonsense mutations introduce a premature stop codon, truncating the protein. Frameshift mutations alter the reading frame, changing all downstream amino acids and often creating premature stop codons.

### What causes point mutations?

Point mutations arise spontaneously through tautomeric shifts, depurination, deamination, and DNA replication errors. They can also be induced by environmental mutagens, including chemical agents (base analogs, alkylating agents, intercalating agents) and radiation (UV light, ionizing radiation).

### What is an example of a disease caused by a point mutation?

Sickle cell anemia is caused by a single A→T transversion in the HBB gene, changing glutamic acid to valine at position 6 of the β-globin chain. Other examples include cystic fibrosis (caused by various CFTR mutations), Huntington's disease (caused by trinucleotide repeat expansion, not a simple point mutation), and many cancers (e.g., KRAS mutations in pancreatic cancer).

### How are point mutations detected?

Point mutations are detected using Sanger sequencing, next-generation sequencing, restriction fragment length polymorphism (RFLP) analysis, allele-specific PCR, TaqMan probes, and DNA microarrays. The choice of method depends on the number of samples, the number of mutations being screened, and the required sensitivity.

### Can point mutations be repaired?

Yes, cells have multiple DNA repair pathways that correct point mutations. Base excision repair fixes small base lesions, nucleotide excision repair removes bulky adducts, and mismatch repair corrects replication errors. When these pathways fail, mutation rates increase, leading to diseases such as cancer.

### Are all point mutations harmful?

No. Many point mutations are neutral, particularly silent mutations that do not change the amino acid sequence. Some point mutations are beneficial, providing adaptive advantages such as drug resistance in pathogens or resistance to infectious diseases in humans (e.g., the CCR5-Δ32 mutation confers HIV resistance). The effect of a point mutation depends on its location, type, and the selective environment.

## Key Takeaways

- A point mutation is a single-nucleotide change in DNA, classified as a substitution (transition or transversion) or an indel (insertion or deletion).
- Point mutations arise spontaneously through tautomeric shifts, depurination, deamination, and replication errors, or are induced by chemical mutagens and radiation.
- The effect on protein function depends on the mutation type: silent (no amino acid change), missense (amino acid substitution), nonsense (premature stop), or frameshift (reading frame disruption).
- Point mutations cause numerous human diseases, including sickle cell anemia, cystic fibrosis, and many cancers through oncogene activation and tumor suppressor inactivation.
- Detection methods include Sanger sequencing, NGS, RFLP analysis, allele-specific PCR, and microarrays, each with specific strengths and limitations.
- DNA repair pathways (BER, NER, MMR) correct point mutations; their failure increases mutation rates and disease risk.
- Not all point mutations are harmful—many are neutral, and some provide adaptive advantages, underscoring the dual role of mutations in disease and evolution.

## Further Reading

- Tan X et al. *Clinical significance of a point mutation in DNA polymerase beta (POLB) gene in gastric cancer*. International journal of biological sciences. 2015. [PubMed 25561897](https://doi.org/10.7150/ijbs.10692)
- Ye M et al. *A novel method for the detection of point mutation in DNA using single-base-coded CdS nanoprobes*. Biosensors & bioelectronics. 2009. [PubMed 19135353](https://doi.org/10.1016/j.bios.2008.12.002)
- Newton CR et al. *Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS)*. [Nucleic acids research](/blog/news/nucleic-acids-research). 1989. [PubMed 2785681](https://doi.org/10.1093/nar/17.7.2503)
- Tan X et al. *A Point Mutation in DNA Polymerase β (POLB) Gene Is Associated with Increased Progesterone Receptor (PR) Expression and Intraperitoneal Metastasis in Gastric Cancer*. Journal of Cancer. 2016. [PubMed 27471563](https://doi.org/10.7150/jca.14844)
- Kim T et al. *Fluorescence-based detection of point mutation in DNA sequences by CdS quantum dot aggregation*. The journal of physical chemistry. B. 2009. [PubMed 19810696](https://doi.org/10.1021/jp906096a)
- Little S. *Amplification-refractory mutation system (ARMS) analysis of point mutations*. Current protocols in human genetics. 2001. [PubMed 18428319](https://doi.org/10.1002/0471142905.hg0908s07)

## Related Clinical & Scientific Guides

* [MAPK Pathway: Mechanism, Function, and Clinical Relevance](/knowledge/molecular-biology/mapk-pathway)
* [Mammalian Cell Culture Bioreactors: A Practical Guide](/knowledge/molecular-biology/mammalian-cell-culture-bioreactor)
* [Nucleotide Formation: Biosynthesis and Assembly of DNA/RNA Building Blocks](/knowledge/molecular-biology/nucleotide-formation)